¹⁹F-MRI for monitoring human NK cells in vivo

References

• Arai S, Meagher R, Swearingen M, Myint H, Rich E, Martinson J, Klingemann H. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy 2008; 10:625-32; PMID:18836917; http://dx.doi.org/10.1080/14653240802301872
   PubMed Web of Science ®Google Scholar
• deMagalhaes-Silverman M, Donnenberg A, Lembersky B, Elder E, Lister J, Rybka W, Whiteside T, Ball E. Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer. J Immunother 2000; 23:154-60; PMID:10687148; http://dx.doi.org/10.1097/00002371-200001000-00018
   PubMed Web of Science ®Google Scholar
• Geller MA, Cooley S, Judson PL, Ghebre R, Carson LF, Argenta PA, Jonson AL, Panoskaltsis-Mortari A, Curtsinger J, McKenna D et al. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy 2011; 13:98-107; PMID:20849361; http://dx.doi.org/10.3109/14653249.2010.515582
   PubMed Web of Science ®Google Scholar
• Lister J, Rybka WB, Donnenberg AD, deMagalhaes-Silverman M, Pincus SM, Bloom EJ, Elder EM, Ball ED, Whiteside TL. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period. Clin Cancer Res 1995; 1:607-14; PMID:9816022
   PubMed Web of Science ®Google Scholar
• Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005 Apr 15; 105(8):3051-; PMID:15632206; http://dx.doi.org/10.1182/blood-2004-07-2974
   Google Scholar
• Tonn T, Schwabe D, Klingemann HG, Becker S, Esser R, Koehl U, Suttorp M, Seifried E, Ottmann OG, Bug G. Treatment of patients with advanced cancer with the natural killer cell line NK-92. Cytotherapy 2013; 15:1563-70; PMID:24094496; http://dx.doi.org/10.1016/j.jcyt.2013.06.017
   PubMed Web of Science ®Google Scholar
• Minutes. Meeting #45. Food and Drug Administration Center for Biologics Evaluation and Research April 10 and 11, 2008; Cell, Tissue and Gene Therapies Advisory Committee.
   Google Scholar
• Jha P, Golovko D, Bains S, Hostetter D, Meier R, Wendland MF, Daldrup-Link HE. Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities. Cancer Res 2010; 70:6109-13; PMID:20631071; http://dx.doi.org/10.1158/0008-5472.CAN-09-3774
   PubMed Web of Science ®Google Scholar
• Sta Maria NS, Barnes SR, Jacobs RE. In vivo monitoring of natural killer cell trafficking during tumor immunotherapy. Magn Reson Insights 2014; 7:15-21; PMID:25114550; http://dx.doi.org/10.4137/MRI.S13145
   PubMedGoogle Scholar
• Daldrup-Link HE, Meier R, Rudelius M, Piontek G, Piert M, Metz S, Settles M, Uherek C, Wels W, Schlegel J et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 2005; 15:4-13; PMID:15616814; http://dx.doi.org/10.1007/s00330-004-2526-7
   PubMed Web of Science ®Google Scholar
• Mallett CL, McFadden C, Chen Y, Foster PJ. Migration of iron-labeled KHYG-1 natural killer cells to subcutaneous tumors in nude mice, as detected by magnetic resonance imaging. Cytotherapy 2012; 14:743-51; PMID:22443465; http://dx.doi.org/10.3109/14653249.2012.667874
   PubMed Web of Science ®Google Scholar
• Meier R, Golovko D, Tavri S, Henning TD, Knopp C, Piontek G, Rudelius M, Heinrich P, Wels WS, Daldrup-Link, H. Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging. Magn Reson Med: Off J Soc Magnet Resonance Med / Soc Magnet Resonance Med 2011; 65:756-63; PMID:20928869; http://dx.doi.org/10.1002/mrm.22652
   PubMed Web of Science ®Google Scholar
• Sheu AY, Zhang Z, Omary RA, Larson AC. MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model. Invest Radiol 2013; 48:492-9; PMID:23249649; http://dx.doi.org/10.1097/RLI.0b013e31827994e5
   PubMed Web of Science ®Google Scholar
• Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005; 23:983-7; PMID:16041364; http://dx.doi.org/10.1038/nbt1121
   PubMed Web of Science ®Google Scholar
• Ruiz-Cabello J, Barnett BP, Bottomley PA, Bulte JW. Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed 2011; 24:114-29; PMID:20842758; http://dx.doi.org/10.1002/nbm.1570
   PubMed Web of Science ®Google Scholar
• Grégoire C, Cognet C, Chasson L, Coupet C-A, Dalod M, Reboldi A, Marvel J, Sallusto F, Vivier E, Walzer T. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Euro J Immunol 2008; 38:2076-84; PMID:18624307; http://dx.doi.org/10.1002/eji.200838550
   PubMed Web of Science ®Google Scholar
• Liou HLR, Myers JT, Barkauskas DS, Huang AY. Intravital imaging of the mouse popliteal lymph node. 2012:e3720. J Vis Exp. 2012 Feb 8; (60). pii: 3720. PMID: 22349264; http://dx.doi.org/10.3791/3720
   Google Scholar
• Olson JA, Zeiser R, Beilhack A, Goldman JJ, Negrin RS. Tissue-specific homing and expansion of donor NK cells in allogeneic one marrow transplantation. J Immunol 2009; 183:3219-28; PMID:19657090; http://dx.doi.org/10.4049/jimmunol.0804268
   PubMed Web of Science ®Google Scholar
• F.D.A. US. White paper: initiative to reduce unnecessary radiation exposure from medical imaging.
   Google Scholar
• Ahrens ET, Bulte JW. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 2013; 13:755-63; PMID:24013185; http://dx.doi.org/10.1038/nri3531
   PubMed Web of Science ®Google Scholar
• Ahrens ET, Zhong J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed 2013; 26:860-71; PMID:23606473; http://dx.doi.org/10.1002/nbm.2948
   PubMed Web of Science ®Google Scholar
• Hu L, Hockett FD, Chen J, Zhang L, Caruthers SD, Lanza GM, Wickline SA. A generalized strategy for designing (19)F/(1)H dual-frequency MRI coil for small animal imaging at 4.7 Tesla. J Magn Reson Imaging: JMRI 2011; 34:245-52; PMID:21698714; http://dx.doi.org/10.1002/jmri.22516
   PubMed Web of Science ®Google Scholar
• Lim YT, Cho MY, Noh YW, Chung JW, Chung BH. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy. Nanotechnology 2009; 20:475102; PMID:19875875; http://dx.doi.org/10.1088/0957-4484/20/47/475102
   PubMed Web of Science ®Google Scholar
• Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2011; 65:1144-53; PMID:21305593; http://dx.doi.org/10.1002/mrm.22702
   PubMed Web of Science ®Google Scholar
• Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, de Vries IJ, Ahrens ET, Mailliard RB. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 2010; 12:238-50; PMID:20053146; http://dx.doi.org/10.3109/14653240903446902
   PubMed Web of Science ®Google Scholar
• Bonetto F, Srinivas M, Heerschap A, Mailliard R, Ahrens ET, Figdor CG, de Vries IJ. A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer J Int du Cancer 2011; 129:365-73; PMID:20839261; http://dx.doi.org/10.1002/ijc.25672
   PubMed Web of Science ®Google Scholar
• Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med: Off J Soc Mag Reson Med / Soc Magn Reson Med 2007; 58:725-34; PMID:17899609; http://dx.doi.org/10.1002/mrm.21352
   PubMed Web of Science ®Google Scholar
• Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2009; 62:747-53; PMID:19585593; http://dx.doi.org/10.1002/mrm.22063
   PubMed Web of Science ®Google Scholar
• Helfer BM, Balducci A, Sadeghi Z, O'Hanlon C, Hijaz A, Flask CA, Wesa A. (1)(9)F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells. Cell Transplant 2013; 22:87-97; PMID:22862925; http://dx.doi.org/10.3727/096368912X653174
   PubMed Web of Science ®Google Scholar
• Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW. In vivo “hot spot” MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med: Off J Soc Magn Reson Med/ Soc Magn Reson Med 2008; 60:1506-11; PMID:19025893; http://dx.doi.org/10.1002/mrm.21783
   PubMed Web of Science ®Google Scholar
• Boehm-Sturm P, Mengler L, Wecker S, Hoehn M, Kallur T. In vivo tracking of human neural stem cells with 19F magnetic resonance imaging. PloS One 2011; 6:e29040; PMID:22216163; http://dx.doi.org/10.1371/journal.pone.0029040
   PubMedGoogle Scholar
• Gaudet JM, Ribot EJ, Chen Y, Gilbert KM, Foster PJ. Tracking the fate of stem cell implants with fluorine-19 MRI. PloS One 2015; 10:e0118544; PMID:25767871; http://dx.doi.org/10.1371/journal.pone.0118544
   PubMedGoogle Scholar
• Ribot EJ, Gaudet JM, Chen Y, Gilbert KM, Foster PJ. In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence. Int J Nanomed 2014; 9:1731-9; PMID:24748787; http://dx.doi.org/10.2147/IJN.S59127
   PubMed Web of Science ®Google Scholar
• Ahrens ET, Helfer BM, O'Hanlon CF, Schirda C. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2014; 72:1696-701; PMID:25241945; http://dx.doi.org/10.1002/mrm.25454
   PubMed Web of Science ®Google Scholar
• Lim YT, Cho MY, Kang JH, Noh YW, Cho JH, Hong KS, Chung JW, Chung BH. Perfluorodecalin/[InGaP/ZnS quantum dots] nanoemulsions as 19F MR/optical imaging nanoprobes for the labeling of phagocytic and nonphagocytic immune cells. Biomaterials 2010; 31:4964-71; PMID:20346494; http://dx.doi.org/10.1016/j.biomaterials.2010.02.065
   PubMed Web of Science ®Google Scholar
• Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, Boles KS, Andrews DM, Smyth MJ, Colonna M. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med 2008; 205:2965-73; PMID:19029380; http://dx.doi.org/10.1084/jem.20081752
   PubMed Web of Science ®Google Scholar
• Buhtoiarov IN, Neal ZC, Gan J, Buhtoiarova TN, Patankar MS, Gubbels JA, Hank JA, Yamane B, Rakhmilevich AL, Reisfeld RA et al. Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting. J Leukocyte Biol 2011; 89:625-38; PMID:21248148; http://dx.doi.org/10.1189/jlb.0710422
   PubMed Web of Science ®Google Scholar
• Neal ZC, Yang JC, Rakhmilevich AL, Buhtoiarov IN, Lum HE, Imboden M, Hank JA, Lode HN, Reisfeld RA, Gillies SD et al. Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy. Clin Cancer Res: Off J Am Assoc Cancer Res 2004; 10:4839-47; PMID:15269160; http://dx.doi.org/10.1158/1078-0432.CCR-03-0799
   PubMed Web of Science ®Google Scholar
• Lode HN, Xiang R, Dreier T, Varki NM, Gillies SD, Reisfeld RA. Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood 1998; 91:1706-15; PMID:9473237
   PubMed Web of Science ®Google Scholar
• Yang RK, Kalogriopoulos NA, Rakhmilevich AL, Ranheim EA, Seo S, Kim K, Alderson KL, Gan J, Reisfeld RA, Gillies SD et al. Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival. Cancer Immunol, Immunother: CII 2013; 62:1303-13; PMID:23661160; http://dx.doi.org/10.1007/s00262-013-1430-x
   PubMed Web of Science ®Google Scholar
• Shusterman S, London WB, Gillies SD, Hank JA, Voss SD, Seeger RC, Reynolds CP, Kimball J, Albertini MR, Wagner B et al. Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol: Off J Am Soc Clin Oncol 2010; 28:4969-75; PMID:20921469; http://dx.doi.org/10.1200/JCO.2009.27.8861
   PubMed Web of Science ®Google Scholar
• Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C et al. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Clin Cancer Res: Off J Am Assoc Cancer Res 2006; 12:1750-9; PMID:16551859; http://dx.doi.org/10.1158/1078-0432.CCR-05-2000
   PubMed Web of Science ®Google Scholar
• Albertini MR, Hank JA, Gadbaw B, Kostlevy J, Haldeman J, Schalch H, Gan J, Kim K, Eickhoff J, Gillies SD et al. Phase II trial of hu14.18-IL2 for patients with metastatic melanoma. Cancer Immunol, Immunother: CII 2012; 61:2261-71; PMID:22678096; http://dx.doi.org/10.1007/s00262-012-1286-5
   PubMed Web of Science ®Google Scholar
• Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 2013; 10:230-52; PMID:23604045; http://dx.doi.org/10.1038/cmi.2013.10
   PubMed Web of Science ®Google Scholar
• Spahn DR. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 1999; 3:R93-7; PMID:11094488; http://dx.doi.org/10.1186/cc364
   PubMed Web of Science ®Google Scholar
• Bansal A, Pandey MK, Demirhan YE, Nesbitt JJ, Crespo-Diaz RJ, Terzic A, Behfar A, DeGrado TR. Novel (89)Zr cell labeling approach for PET-based cell trafficking studies. EJNMMI Res 2015; 5:19; PMID:25918673; http://dx.doi.org/10.1186/s13550-015-0098-y
   PubMed Web of Science ®Google Scholar
• van de Watering FC, Rijpkema M, Perk L, Brinkmann U, Oyen WJ, Boerman OC. Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients. Biomed Res Int 2014; 2014:203601; PMID:24991539 ; http://dx.doi.org/10.1155/2014/203601
   PubMed Web of Science ®Google Scholar
• Sato N, Wu H, Asiedu KO, Szajek LP, Griffiths GL, Choyke PL. (89)Zr-oxine complex PET cell imaging in monitoring cell-based therapies. Radiology 2015; 275:490-500; PMID:25706654; http://dx.doi.org/10.1148/radiol.15142849
   PubMed Web of Science ®Google Scholar
• Brand JM, Meller B, Von Hof K, Luhm J, Bahre M, Kirchner H, Frohn C. Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev 2004; 13:307-14; PMID:15186726; http://dx.doi.org/10.1089/154732804323099235
   PubMed Web of Science ®Google Scholar
• Meller B, Frohn C, Brand JM, Lauer I, Schelper LF, von Hof K, Kirchner H, Richter E, Baehre M. Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma. Euro J Nuclear Med Mol Imaging 2004; 31:403-7; PMID:14685783; http://dx.doi.org/10.1007/s00259-003-1398-4
   PubMed Web of Science ®Google Scholar
• Matera L, Galetto A, Bello M, Baiocco C, Chiappino I, Castellano G, Stacchini A, Satolli MA, Mele M, Sandrucci S et al. In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma. J Transl Med 2006; 4:49; PMID:17105663; http://dx.doi.org/10.1186/1479-5876-4-49
   PubMed Web of Science ®Google Scholar
• Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-tracking methods. Nat Rev Clin Oncol 2011; 8:677-88; PMID:21946842; http://dx.doi.org/10.1038/nrclinonc.2011.141
   PubMed Web of Science ®Google Scholar
• Tavri S, Jha P, Meier R, Henning TD, Muller T, Hostetter D, Knopp C, Johansson M, Reinhart V, Boddington S et al. Optical imaging of cellular immunotherapy against prostate cancer. Mol Imaging 2009; 8:15-26; PMID:19344572 ; http://dx.doi.org/10.2310/7290.2009.00002
   PubMed Web of Science ®Google Scholar
• Jang ES, Shin JH, Ren G, Park MJ, Cheng K, Chen X, Wu JC, Sunwoo JB, Cheng Z. The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles. Biomaterials 2012; 33:5584-92; PMID:22575830; http://dx.doi.org/10.1016/j.biomaterials.2012.04.041
   PubMed Web of Science ®Google Scholar
• Olson JA, Zeiser R, Beilhack A, Goldman JJ, Negrin RS. Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation. J Immunol 2009; 183:3219-28; PMID:25241945; http://dx.doi.org/10.4049/jimmunol.0804268
   PubMed Web of Science ®Google Scholar
• Beuneu H, Deguine J, Breart B, Mandelboim O, Di Santo JP, Bousso P. Dynamic behavior of NK cells during activation in lymph nodes. Blood 2009; 114:3227-34; PMID:19667398; http://dx.doi.org/10.1182/blood-2009-06-228759
   PubMed Web of Science ®Google Scholar
• Sutton EJ, Henning TD, Pichler BJ, Bremer C, Daldrup-Link HE. Cell tracking with optical imaging. Eur Radiol 2008; 18:2021-32; PMID:18506449; http://dx.doi.org/10.1007/s00330-008-0984-z
   PubMed Web of Science ®Google Scholar
• Duval L, Schmidt H, Kaltoft K, Fode K, Jensen JJ, Sorensen SM, Nishimura MI, von der Maase H. Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma. Clin Cancer Res: Off J Am Assoc Cancer Res 2006; 12:1229-36; PMID:16489078; http://dx.doi.org/10.1158/1078-0432.CCR-05-1485
   PubMed Web of Science ®Google Scholar
• Hasumi K, Aoki Y, Wantanabe R, Mann DL. Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy. Oncoimmunology 2013; 2:e26381; PMID:24349874; http://dx.doi.org/10.4161/onci.26381
   PubMed Web of Science ®Google Scholar
• Schmid F, Holtke C, Parker D, Faber C. Boosting (19) F MRI-SNR efficient detection of paramagnetic contrast agents using ultrafast sequences. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2013; 69:1056-62; PMID:19657090; http://dx.doi.org/10.1002/mrm.24341
   PubMed Web of Science ®Google Scholar
• Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2013; 70:1241-50; PMID:23213020; http://dx.doi.org/10.1002/mrm.24570
   PubMed Web of Science ®Google Scholar
• Weiger M, Pruessmann KP, Hennel F. MRI with zero echo time: hard versus sweep pulse excitation. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2011; 66:379-89; PMID:21381099; http://dx.doi.org/10.1002/mrm.22799
   PubMed Web of Science ®Google Scholar
• Grodzki DM, Jakob PM, Heismann B. Ultrashort echo time imaging using pointwise encoding time reduction with radial acquisition (PETRA). Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 2012; 67:510-8; http://dx.doi.org/10.1002/mrm.23017
   Web of Science ®Google Scholar